Arsenic Levels Higher in Patients With Nonmelanoma Skin Cancers

This article originally appeared here.
Share this content:
Arsenic Levels Higher in Patients With Nonmelanoma Skin Cancers
Arsenic Levels Higher in Patients With Nonmelanoma Skin Cancers

MONDAY, Aug. 21, 2017 (HealthDay News) -- Certain arsenic species levels are higher among patients with nonmelanoma skin cancer (NMSC), according to a study published online Aug. 16 in the Journal of Dermatology.

Tae-Hoon Kim, from Dong-A University in Busan, South Korea, and colleagues compared the creatinine-adjusted urinary concentration of arsenic species in NMSC patients and community controls to validate the contribution of each arsenic species to NMSC. Data were included for 124 biopsy-proven NMSC cases and 125 age- and sex-matched community controls, drinking tap water with a low-level arsenic concentration.

The researchers observed significantly higher levels of total inorganic arsenic, trivalent and pentavalent arsenic, and monomethylarsonic acid for the NMSC group than controls. The NMSC group had lower total arsenic, organic arsenic, and dimethylarsonic acid levels.

"We suggest that inorganic arsenic species, trivalent arsenic, and pentavalent arsenic may influence the prevalence of NMSC, in spite of these levels being lower than the Agency for Toxic Substances and Disease Registry-recommended standard or the levels reported by other highly contaminated areas and neighboring countries in East Asia," the authors write. "Furthermore, it also suggests that total arsenic level cannot represent the risk of NMSC."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Ground Beef Recalled After E. Coli Outbreak

Ground Beef Recalled After <i>E. Coli</i> Outbreak

Beef was produced and packaged at Cargill Meat Solutions in Fort Morgan, Colo.

Prevalence of Alzheimer's, Related Dementia Set to Double

Prevalence of Alzheimer's, Related Dementia Set to Double

Alzheimer's disease and related dementias burden is expected to increase to 3.3 percent in 2060

Long-Term Outcomes of Breast Implants Explored

Long-Term Outcomes of Breast Implants Explored

Higher rates of Sjogren syndrome, scleroderma, RA, stillbirth, melanoma for silicone implants

is free, fast, and customized just for you!




Already a member?

Sign In Now »